Navigation Links
Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller
Date:2/22/2010

ogram, which is being developed for the rapid treatment of agitation in schizophrenic or bipolar disorder patients.  Alexza has completed and announced positive results from both of its AZ-004 Phase 3 clinical trials, submitted a New Drug Application submission in December 2009, and has a Prescription Drug User Fee Act (PDUFA) goal date of October 11, 2010.  In February 2010, Alexza established a partnership with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation (NYSE: BVF), to develop and commercialize AZ-004 in the U.S. and Canada.

Alexza has completed an end-of-Phase 2 meeting with the FDA for AZ-001 (Staccato prochlorperazine) and has completed two Phase 2 studies with AZ-104 (Staccato loxapine, low-dose).  Both product candidates are being developed for the acute treatment of migraine headache.

AZ-002 (Staccato alprazolam) has completed Phase 1 testing and one Phase 2a proof-of-concept clinical trial.  Product candidates that have completed Phase 1 testing are AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, and AZ-007 (Staccato zaleplon) for the treatment of insomnia.  More information, including this and past press releases from Alexza, is available online at

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010
2. Alexza Announces AZ-004 (Staccato(R) Loxapine) PDUFA Goal Date of October 11, 2010
3. Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA
4. Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
5. Alexza to Announce 2009 Third Quarter Financial Results and Update Its AZ-004 NDA Status on Monday, November 9, 2009
6. Alexza Pharmaceuticals to Present at the Fourth Annual JMP Securities Healthcare Focus Conference
7. Alexza Announces Preliminary Results from its AZ-104 (Staccato(R) Loxapine) Phase 2b Trial in Patients with Migraine Headache
8. Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
9. Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
10. Alexza Initiates AZ-104 (Staccato(R) Loxapine) Phase 2b Clinical Trial in Patients With Migraine Headaches
11. Alexzas AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... A pharmaceutical executive in the market research ... he wanted the research and consulting firm to explore: ... for secondary research) to maximize efficiency and maintain a ... , Automation of market research processes for efficient ... to implement and manage those automated systems ...
(Date:9/19/2014)... MOUNTAIN VIEW, Calif. , Sept. 19, 2014 /PRNewswire/ ... million in capital from Xiaomi Ventures, Ltd. for its ... be used to continue expanding iHealth,s global reach, accelerate ... marketing resources.  As part of the investment, Xiaomi Ventures ... in the areas of cloud infrastructure and ecommerce. ...
(Date:9/19/2014)... 2014 According to the ... Heat, therapy, Hydrotherapy), Accessories (Posture Mirror, Exercise Ball), Applications ... - Global Forecast to 2019" published by MarketsandMarkets, the ... $19,786.3 Million by 2019 from $14,240.0 Million in ... to 2019. Browse 74 market data ...
Breaking Medicine Technology:In Era of Competing Needs, Market Research Groups Under Pressure to Utilize Automation and External Staffing 2iHealth Raises $25 Million to Fuel Growth and Global Market Share 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 4
... 25, 2011 Reportlinker.com announces ... report is available in its ... Devices Market to 2017 - ... Neurostimulation Devices in Multiple Neurological ...
... 2011 Reportlinker.com announces that ... is available in its catalogue: ... Healthcare Equipment Market to 2017 ... Diseases in the Elderly Population ...
Cached Medicine Technology:Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 2Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 3Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 4Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 5Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 6Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 7Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 8Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 9Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 10Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 11Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 12Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth 13Home Healthcare Equipment Market to 2017 - Increased Prevalence of Chronic Diseases in the Elderly Population to Stimulate Growth 2Home Healthcare Equipment Market to 2017 - Increased Prevalence of Chronic Diseases in the Elderly Population to Stimulate Growth 3Home Healthcare Equipment Market to 2017 - Increased Prevalence of Chronic Diseases in the Elderly Population to Stimulate Growth 4Home Healthcare Equipment Market to 2017 - Increased Prevalence of Chronic Diseases in the Elderly Population to Stimulate Growth 5Home Healthcare Equipment Market to 2017 - Increased Prevalence of Chronic Diseases in the Elderly Population to Stimulate Growth 6Home Healthcare Equipment Market to 2017 - Increased Prevalence of Chronic Diseases in the Elderly Population to Stimulate Growth 7Home Healthcare Equipment Market to 2017 - Increased Prevalence of Chronic Diseases in the Elderly Population to Stimulate Growth 8Home Healthcare Equipment Market to 2017 - Increased Prevalence of Chronic Diseases in the Elderly Population to Stimulate Growth 9Home Healthcare Equipment Market to 2017 - Increased Prevalence of Chronic Diseases in the Elderly Population to Stimulate Growth 10Home Healthcare Equipment Market to 2017 - Increased Prevalence of Chronic Diseases in the Elderly Population to Stimulate Growth 11Home Healthcare Equipment Market to 2017 - Increased Prevalence of Chronic Diseases in the Elderly Population to Stimulate Growth 12Home Healthcare Equipment Market to 2017 - Increased Prevalence of Chronic Diseases in the Elderly Population to Stimulate Growth 13
(Date:9/19/2014)... By Alan Mozes ... (HealthDay News) -- Cancer patients burdened by stress and ... for complications following their operation, a new study suggests. ... "deficit" appeared to have a nearly three times greater ... or good quality of life. "We,ve long known ...
(Date:9/19/2014)... leading anti-ageing clinic has called its HGH Therapy ... grown tremendously across USA in the last decade with new ... has far reaching benefits for ageing men and women and ... active lifestyle even beyond their middle age. , Explaining ... said, “HGH or Human Growth hormones are the building blocks ...
(Date:9/19/2014)... IRVINE, CA (PRWEB) September 19, 2014 In ... has been an active part of the project’s social ... this movement, which aims to re-define the perception of beauty ... Beauty Project began as an idea by Shelly Baer and ... showed disabled women as sexy and beautiful. Ginny Dixon, Wendy ...
(Date:9/19/2014)... two-generation approaches to reducing poverty that help children ... researchers, advocates, and foundations. By combining education and ... to jobs that offer a path out of ... children, these programs aim to improve the life ... new report from the National Center for Children ...
(Date:9/19/2014)... Hills, NY (PRWEB) September 20, 2014 As ... Prabha Krishnan DMD in Queens, NY now reminds area patients ... more than 80% of our population affected by gum disease, ... any longer.” , For over 20 years Dr. Krishnan has ... Forest Hills office location. “Most patients that come in due ...
Breaking Medicine News(10 mins):Health News:Family Squabbles Can Derail Recovery From Cancer Surgery 2Health News:Family Squabbles Can Derail Recovery From Cancer Surgery 3Health News:MetroMD Announces Better HGH Therapy - the ‘God Particle’ of Human Health 2Health News:OC Healthcare Agency StudioPMG Partners with The Raw Beauty Project ™ NYC 2014 2Health News:A two generation lens: Current state policies fail to support families with young children 2Health News:New York Periodontist Dr. Prabha Krishnan Now Raises Awareness about the Dangers of Untreated Decay, Gingivitis and Gum Disease During Self-Awareness Month 2Health News:New York Periodontist Dr. Prabha Krishnan Now Raises Awareness about the Dangers of Untreated Decay, Gingivitis and Gum Disease During Self-Awareness Month 3
... ARBOR, Mich. Only a third of patients with ... before their initial surgery, according to a new study ... Whats more, women who did discuss reconstruction up front ... compared to those women who did not discuss reconstruction. ...
... Calif., Dec. 20 ISTA Pharmaceuticals,Inc. (Nasdaq: ... a New Drug,Application (NDA) to the U.S. Food ... Company is seeking approval for Xibrom QD,as a ... Xibrom(TM) (bromfenac ophthalmic solution), Xibrom is ...
... New research,published in the December issue of Pediatrics ... can lose weight while substituting an,ounce of peanuts ... choices. The,study, "Weight Loss in Overweight Mexican American ... and Overweight" (FLOW),Prevention Program, which is in a ...
... Mich., Dec. 20 Oakwood Healthcare,Inc. (OHI) today became ... most up-to-date and comprehensive pricing information for,hundreds of surgeries, ... This is a natural step forward as Oakwood was,the ... key,quality outcomes on its Web site more than two ...
... of Howard G. Smith,announces a September 4, 2007, ... in,the securities class action lawsuit filed on behalf ... Pharmaceuticals, Inc. ("Threshold,Pharmaceuticals" or the "Company")(Nasdaq: THLD ... (the "Class Period"), including purchasers in Threshold,s,February 4, ...
... humanitarian organization distorts ... history and law, WASHINGTON, Aug. ... Johnson & Johnson (J&J), the American,Red Cross today released a detailed rebuttal, ... emblem. "The mission of the Red Cross is to prevent, prepare ...
Cached Medicine News:Health News:Most breast cancer surgeons don't talk to patients about reconstruction options, U-M study finds 2Health News:ISTA Pharmaceuticals Submits New Drug Application for Xibrom(TM) QD (once-daily) 2Health News:Overweight Kids Lose Weight Eating Peanuts Every Day in School-Based Study 2Health News:Overweight Kids Lose Weight Eating Peanuts Every Day in School-Based Study 3Health News:Oakwood is First Healthcare System in Southeast Michigan to Post Pricing Information on Web Site 2Health News:Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Threshold Pharmaceuticals, Inc. 2Health News:American Red Cross Defends Use of Emblem and Mission 2Health News:American Red Cross Defends Use of Emblem and Mission 3Health News:American Red Cross Defends Use of Emblem and Mission 4Health News:American Red Cross Defends Use of Emblem and Mission 5Health News:American Red Cross Defends Use of Emblem and Mission 6
4 mm disposable bevel blade. Malleable shafts. Flat spot on handle designed to guide knife in perforation....
Consist of 6 disposable bevel blades (N0522) and chuck handle (0521). Malleable shafts. Designated most popular model or size....
Straight 9 mm downcutting Royce blade. Can be placed in closed handle for protection. Handle length folded 109 mm, 4.3 inches. Blade can be set automatically and rigidly at any point from straight to...
2 mm diameter blade. Angled 60 degrees. Sharp. Round handle....
Medicine Products: